Scientific Sessions 2025  /  Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies – A Hypertension/AHA Journals Session  /  Aldosterone synthase inhibitors – a potentially new class of antihypertensive drugs
Logo

American Heart Association

  60
  0

Final ID:

Aldosterone synthase inhibitors – a potentially new class of antihypertensive drugs

  • Laffin, Luke  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Luther, James  ( VANDERBILT UNIV MED CTR , Nashville , Tennessee , United States )
  • Kline, Gregory  ( University of Calgary , Calgary , Alberta , Canada )
    • Author Disclosures:
    Luke Laffin: DO have relevant financial relationships ; Research Funding (PI or named investigator):Mineralys:Active (exists now) ; Consultant:Ripple Medical:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Recor:Active (exists now) ; Royalties/Patent Beneficiary:Elsevier:Active (exists now) ; Research Funding (PI or named investigator):Eli Lilly:Active (exists now) ; Advisor:Novartis:Active (exists now) ; Advisor:Crispr Theapeutics:Active (exists now) ; Research Funding (PI or named investigator):Kardigan:Active (exists now) ; Consultant:Astrazeneca:Active (exists now) ; Research Funding (PI or named investigator):Arrowhead:Active (exists now) | James Luther: DO have relevant financial relationships ; Consultant:Mineralys:Active (exists now) ; Other (please indicate in the box next to the company name):AHA (editorial board):Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) | Gregory Kline: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies – A Hypertension/AHA Journals Session

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Aldosterone and mineralocorticoid receptors beyond the kidney

Jaffe Iris, Harrison David, Jaisser Frederic

‘Primarily Aldosteronism’: from genetic diversity to resisting Hypertension

Brown Morris, Williams Tracy, Zennaro Maria-christina

More abstracts from these authors:
Should I treat this patients Hypertension in the hospital?

Luther James, Moloney David

Efficacy and Safety of Lorundrostat in Hypertension Patients with High Unmet Medical Need: Subgroup Analyses of the Launch-HTN Trial in Uncontrolled and Treatment-Resistant Hypertension

Saxena Manish, Laffin Luke, Luther James, Weir Matthew, Kopjar Branko, Rodman David

You have to be authorized to contact abstract author. Please, Login
Not Available